Digirad (NASDAQ: DRAD) and Viveve Medical (NASDAQ:VIVE) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, profitability, earnings and valuation.
Insider and Institutional Ownership
56.0% of Digirad shares are held by institutional investors. Comparatively, 67.4% of Viveve Medical shares are held by institutional investors. 11.9% of Digirad shares are held by insiders. Comparatively, 35.1% of Viveve Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
This is a breakdown of recent recommendations for Digirad and Viveve Medical, as reported by MarketBeat.
||Strong Buy Ratings
Digirad currently has a consensus price target of $6.00, suggesting a potential upside of 252.94%. Viveve Medical has a consensus price target of $9.20, suggesting a potential upside of 237.00%. Given Digirad’s stronger consensus rating and higher possible upside, equities research analysts plainly believe Digirad is more favorable than Viveve Medical.
Risk and Volatility
Digirad has a beta of 2.08, meaning that its share price is 108% more volatile than the S&P 500. Comparatively, Viveve Medical has a beta of -0.47, meaning that its share price is 147% less volatile than the S&P 500.
Earnings & Valuation
This table compares Digirad and Viveve Medical’s gross revenue, earnings per share and valuation.
||Earnings Per Share
Digirad has higher revenue and earnings than Viveve Medical.
This table compares Digirad and Viveve Medical’s net margins, return on equity and return on assets.
||Return on Equity
||Return on Assets
Digirad pays an annual dividend of $0.22 per share and has a dividend yield of 12.9%. Viveve Medical does not pay a dividend.
Digirad beats Viveve Medical on 9 of the 13 factors compared between the two stocks.
Digirad Corporation provides healthcare solutions in the United States. It operates through Diagnostic Services, Mobile Healthcare, and Diagnostic Imaging segments. The Diagnostic Services segment provides nuclear and ultrasound imaging services to physicians who perform nuclear imaging, echocardiography, vascular or general ultrasound tests, imaging systems, radiopharmaceuticals, and licensing services, as well as offers remote cardiac event monitoring services. The Mobile Healthcare segment offers contract diagnostic imaging services, including computerized tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), PET/CT, and nuclear medicine and healthcare services to hospitals, integrated delivery networks, and federal institutions on a long-term contract basis, as well as provisional services to institutions that are in transition. The Diagnostic Imaging segment develops and sells gamma camera imaging systems, such as nuclear cardiac imaging systems and general purpose nuclear imaging systems to physician offices and hospitals; and offers camera maintenance services. Digirad Corporation was founded in 1985 and is headquartered in Suwanee, Georgia.
About Viveve Medical
Viveve Medical, Inc. designs, develops, manufactures, and markets medical devices for the non-invasive treatment of various post-partum conditions. The company offers Viveve System, a radio frequency generator, a reusable hand piece, and single-use treatment tip, as well as other consumable accessories. It markets its products through sales employees and distributors in the United States, the Asia Pacific, Europe, the Middle East, Latin America, and Canada. Viveve Medical, Inc. was founded in 2005 and is headquartered in Englewood, Colorado.
Receive News & Ratings for Digirad Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Digirad and related companies with MarketBeat.com's FREE daily email newsletter.